Algorithm for the treatment of schizophrenia in Japan

Area of Science:

• Psychiatry
• Pharmacology
• Clinical Medicine

Background:

• Evidence-based psychopharmacological algorithms for schizophrenia treatment have emerged globally.
• International consensus on a common algorithm is limited by country-specific antipsychotic availability.
• The Japan Psychopharmacology Algorithm (JPA) Project was initiated, inspired by the International Psychopharmacology Algorithm (IPA) Project.

Purpose of the Study:

• To develop a country-specific algorithm for schizophrenia treatment in Japan.
• To compare the developed Japanese algorithm with international guidelines.
• To identify unique aspects of schizophrenia treatment within the Japanese context.

Main Methods:

• Development of the Japan Psychopharmacology Algorithm (JPA) based on available psychotropic medications in Japan.
• Comparison of the JPA algorithm with existing international treatment algorithms for schizophrenia.
• Inclusion of specific treatment strategies relevant to the Japanese pharmaceutical landscape.

Main Results:

• No essential differences were found between the JPA and international algorithms for treating acute schizophrenic episodes.
• Combined use of antipsychotics appears more prevalent in Japanese treatment practices.
• The JPA algorithm incorporates adjunctive treatments like L-DOPS or thyrotropin-releasing hormone for drug-refractory schizophrenia.

Conclusions:

• The JPA algorithm provides a framework for schizophrenia treatment aligned with international standards for acute episodes.
• Japanese treatment protocols for schizophrenia may involve more frequent combined antipsychotic use.
• Novel adjunctive therapies are integrated into the JPA for managing treatment-resistant schizophrenia, reflecting specific clinical needs.